Interview with Hiltrud Brauch

Interview with Hiltrud Brauch, Ph.D., Professor, Deputy Director, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Head of Breast Cancer Susceptibility and Pharmacogenomics (Stuttgart, Germany), Member of RakFond’s Scientific Advisory Board.

Learn how molecular genetics research led to success in some cancer types diagnostics and disease management, why it’s important to predict the likelihood of endocrine therapy efficacy, and what motivates to continue cancer biology research.